Market Overview
Global C-Reactive Protein Testing Market size and share is currently valued atUSD 1,834.23 million in 2023 and is anticipated to generate an estimated revenue of USD 2,331.22 million by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 2.7% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2024 – 2032
C-reactive protein is produced by the liver in response to inflammation, infection, or tissue injury. Elevated CRP levels serve as a marker for a wide range of conditions, from bacterial and viral infections to autoimmune disorders and cardiovascular diseases. CRP testing has become a cornerstone in medical diagnostics due to its sensitivity, rapid turnaround, and applicability in chronic disease management.
Diagnostic laboratories, hospitals, and point-of-care testing (POCT) environments widely use CRP tests to aid in the detection of inflammation, guide antibiotic usage, and monitor disease progression. The increasing clinical value of CRP diagnostic assays in distinguishing between bacterial and viral infections is also contributing to a reduction in unnecessary antibiotic prescriptions, aligning with global antimicrobial stewardship efforts.
Key Market Growth Drivers:
- Rising Prevalence of Chronic and Inflammatory Diseases
The global surge in chronic diseases such as cardiovascular conditions, diabetes, arthritis, and autoimmune disorders has led to increased utilization of CRP testing. Healthcare providers rely on this test to monitor inflammation levels and tailor treatment strategies, making it a valuable component of long-term chronic disease management. - Growing Demand for Point-of-Care Testing
CRP point-of-care testing devices are transforming healthcare delivery, especially in outpatient and rural settings. The ability to obtain rapid results at the bedside or in clinics enables clinicians to make immediate and informed decisions, improving patient outcomes and reducing hospital admissions. - Expansion of Preventive Healthcare and Early Diagnosis
Preventive healthcare initiatives around the world emphasize early detection and monitoring of inflammatory conditions. CRP testing supports these goals by providing insights into subclinical inflammation and helping to identify individuals at risk of developing more serious conditions. - Technological Advancements in Diagnostic Assays
Improvements in CRP test sensitivity, automation, and ease of use have made diagnostic tools more accessible and efficient. Innovations such as high-sensitivity CRP (hs-CRP) assays have further extended the utility of CRP testing, especially in assessing cardiovascular risk. - Impact of Infectious Disease Outbreaks
Infectious diseases such as COVID-19 and influenza have renewed focus on reliable inflammation markers to assess disease severity and guide treatment. CRP testing has proven effective in monitoring infection-related inflammation and evaluating treatment response.
Key Companies:
Several leading diagnostics and medical device companies are shaping the CRP testing landscape with their innovative product portfolios and global distribution capabilities. Key players include:
- Abaxis, Inc.
- Abbott, Danaher
- Aidian
- BODITECH MED, INC.
- F. Getein Biotech, Inc.
- Hoffmann-La Roche Ltd.
- HORIBA, Ltd., Inc.
- Laboratory Corporation of America Holdings
- Merck KGaA
- Ortho Clinical Diagnostics
- Quest Diagnostics
- Randox Laboratories Ltd.
- Roche Ltd.
- Siemens Healthineers AG
- Thermo Fisher Scientific
- Zoetis
Market Segmentation:
C-reactive Protein Testing Market, Assay Type Outlook (Revenue – USD Million, 2019-2032)
- Immuno-turbidimetric Assay
- ELISA
- Clinical
- Non-clinical
- Chemiluminescence Immunoassay
- Others
C-reactive Protein Testing Market, Detection Range Outlook (Revenue – USD Million, 2019-2032)
- hs (high sensitivity) CRP
- Conventional CRP
- cCRP
C-reactive Protein Testing Market, End-use Outlook (Revenue – USD Million, 2019-2032)
- Clinics
- Hospitals
- Laboratories
- Assisted Living Healthcare Facilities
- Home Care Settings
- Others
C-reactive Protein Testing Market, Disease Area Outlook (Revenue – USD Million, 2019-2032)
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Others
Regional Analysis:
North America dominates the CRP testing market, supported by advanced healthcare infrastructure, high prevalence of chronic diseases, and strong investments in diagnostic technologies. The United States leads in both adoption and innovation, with increasing utilization of hs-CRP in preventive cardiology and wellness screenings.
Europe follows closely, driven by widespread awareness of inflammation-related health risks, integrated healthcare systems, and favorable reimbursement policies. Countries such as Germany, the UK, and France show strong demand for both hospital-based and decentralized testing services.
Asia-Pacific is emerging as a high-growth region due to increasing healthcare spending, a large patient population, and the rising burden of lifestyle diseases. Government health initiatives and expanding access to diagnostics in countries like China, India, and Japan are expected to boost market expansion.
Latin America and the Middle East & Africa also present growth opportunities, although adoption is somewhat limited by infrastructure challenges. Nonetheless, international health organizations and local governments are making strides in improving access to diagnostic tools in these regions.
Future Outlook:
The future of the C-reactive Protein Testing Market is poised for continued expansion, fueled by the global shift toward preventive care, personalized medicine, and rapid diagnostics. The integration of CRP tests with digital health platforms and electronic health records will further streamline patient monitoring and data-driven decision-making.
As the demand for minimally invasive, cost-effective, and accurate diagnostic solutions continues to rise, CRP testing will play an increasingly important role in routine health assessments, disease monitoring, and emergency care. With sustained innovation and strategic collaborations, key industry players are expected to enhance accessibility and expand the clinical applications of CRP testing worldwide.
More Trending Report:
Erectile Dysfunction Drugs Market
Durable Medical Equipment Market